Publications describing the use of
Children's Dermatology Life Quality Index CDLQI
1.
Lewis-Jones MS, Finlay AY. The Children’s
Dermatology Life Quality Index (CDLQI): Initial validation and practical use.
British Journal of Dermatology 1995; 132: 942-949.
2.
Finlay AY, Coles EC, Lewis-Jones MS, Blackford
S, Holt PJA, Howard A, Knight AG, Lanigan SW, Logan RA, Long CC, Marks R, Motley
RJ, Roberts DLL, Statham BN, Wilkins J. Quality of life improves after
seeing a dermatologist. British Journal of Dermatology 1998; 139 (Suppl
51): 15.
3.
Ahmed I, Berth-Jones J, Friedmann P,
Graham-Brown R, Cork M, Sowden J, Finlay A, Beard A, Sumner M, Harper JI.
Short course versus continuous course therapy of cyclosporin in severe childhood
atopic dermatitis. British Journal of Dermatology 1998; 139 (Suppl
51): 22.
4.
Emerson RM, Lawson S, Williams HC. Do specialist
eczema clinics benefit children with atopic dermatitis. British Journal
of Dermatology 1998; 139 (Suppl 51): 46.
13.
Titman P S, Barker C, Smith C H. The
psychological impact of chronic eczema on children and families. Br J
Dermatol 2001; 145 (Suppl 59): 128-129.
14.
Chaudhry S, Moss C, Gilmour E. Quality of
life measurements in children with atopic eczema from different ethnic groups in
Birmingham. Br J Dermatol 2001; 145 (Suppl 59): 45.
15.
Poyner TF, Sibley G, Chim DJ. The effects of
a nurse-run clinic in primary care on the quality of life of children with
atopic eczema. Br J Dermatol 2001; 145:
(Suppl 59): 22.
16.
Ben-Gashir MA, Seed P T, Hay RJ. Quality of
life and disease severity are correlated in children with atopic eczema.
JEADV 2001; 15 (Suppl 2): 111.
17.
Eiser C, Morse R. Quality of life measures in
chronic diseases of childhood. Health Technol Assess 2001; 5(4):
pages 31, 35, 37, 43, 143.
18.
Hanifin J, Allen R, De Prost Y,
Luger T. Validation of the eczema area and severity index (EASI) for
atopic dermatitis in 1,533 patients from the pimecrolimus 1% cream clinical
programme. Ann Dermatol Venereol 2002; 129: 1S411.
19.
Verboom P, Hakkaart-Van Roijen L.
The cost effectiveness of pimecrolimus (SDZ ASM 981) topical cream 1%
and corticosteriods in the treatment of atopic dermatitis. Ann Dermatol
Venereol 2002; 129: 1S425.
20.
Chinn D J, Poyner T Sibley G. Randomised
controlled trial of a single dermatology nurse consultant in primary care on the
quality of life of children with atopic eczema. Br J Dermatol 2002;
146: 432-439.
21.
Whalley D, McKenna S, Huels J, Van Assche D.
Pimecrolimus (SDZ ASM 981) in the treatment of paediatric atopic eczema:
Benefit to quality of life and health-related quality of life. Ann
Dermatol Venereol 2002; 129: 1S426.
22.
Taieb C, Nocera T, Verriere F, Martinsic M A,
Bouissou P, Myon E. Impact of skin diseases on the quality of life of
children and their parents. JEADV 2002; 16
(Suppl 1): 267.
23.
Aziah M S, Rosnah T, Mardziah A, Norzila M Z.
Childhood atopic dermatitis: a measurement of quality of life and family
impact. Med J Malaysia 2002; 57:
329-39.
24.
Fivenson D, Arnold R J G, Kaniecki D J, Cohen J L,
Frech F, Finlay A Y. The effect of atopic dermatitis on total burden of
illness and quality of life on adults and children in a large managed care
organisation. J Managed Care Pharmacy 2002;
8 (5): 333-342
25.
Horn H M, Tidman M J. Quality of life in
epidermolysis bullosa. Clin Exp Dermatol 2002; 27(8): 707-710.
26.
Holme S A, Mann I, Sharpe J L, Dykes P J,
Lewis-Jones M S, Finlay A Y. The Childrens’ Dermatology Life Quality Index:
validation of the cartoon version. Br J Dermatol 2003; 148: 285-290.
27.
Beattie P E & Lewis-Jones M S. Impairment of
quality of life in children with skin disease: further validation studies of
the Children’s Dermatology life quality Index © and the Children’s Life quality
Index ©. Br J Dermatol 2003; 149
(Suppl 64): 77-78.
28.
Fleckman P, Hamill G, Weinstock M A. The
National Registry for Ichthyosis and Related disorders - health related quality
of life and patient reported outcomes.
J Invest Dermatol 2003; 121(1): 0420.
29.
Taieb C, Verriere F, Nocera T, Myon E. Impact of
hydrotherapy care on the quality of life of children. JEADV 2003;
17 (Suppl 3): 336.
30.
Chuh A T A. Quality of life in children with
pityriasis rosea: a prospective case control study. Pediatric
Dermatology 2003; 20 No 6: 474-478.
31.
Chuh A T A. Validation of a Cantonese version of
the Children’s Dermatology Life Quality Index. Pediatric
Dermatology 2003; 20 No 6: 479-481.
32.
Nocera T, Veriere F, Myon E, Taieb C. Impact of
hydrotherapy care on the quality of life of children. Quality of Life
Research 2003; 12: 777.
33.
Charman C, Chambers C Williams H. Measuring
atopic dermatitis severity in randomized controlled clinical trials: what
exactly are we measuring? JID 2003; 120 (6): 932-941.
34.
Won C, Seo P, Park Y, Yang J, Lee K, Sung K, Park C,
Kim D, Change H, Won Y Kim K. A multicenter
trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic
dermatitis in Korea. J Dermatolog Treat 2004; 15(1):
30-34.
35.
Grad O, Niren N, Sung J, Law A. Impact of atopic
dermatitis treatment on quality of life: Results from findings in atopic
children with eczema (face) study. J Am Acad Dermatol 2004; 50(3):
P65.
36.
Ben-Gashir M A, Seed P T, Hay R J. Quality of
life and disease severity are correlated in children with atopic dermatitis.
BJD 2004; 150: 284-290.
37.
Austin E, Phillips G, Lewis-Jones S. The
prevalence of fusidic acid-resistant Staphylococcus aureus colonization
in paediatric outpatients with atopic dermatitis. BJD 2004; 151
(Suppl 68):74.
38.
Woo P N, White M I. A family study of
erythrokeratoderma variabilis. BJD 2004; 151 (Suppl 68): 71.
39.
Charman C R, Venn A J, Williams H C. The
patient-orientated eczema measure - development and validation of anew tool for
measuring atopic eczema severity from the patients’ perspective. Pead
Dermatol 2004; 21 (3): 337. Arch Dermatol 2004; 140: 1513-1519.
40.
Finlay A Y, Myon E, Martin N, Verriere F, Taiebl
Ch. Impact of thermal spa on children’s quality of life. JEADV
2004; 18 (Suppl 2) 310.
41.
Holm E A, Esmann S, Jemec. Patient Education and
morbidity in atopic eczema. Dermatol Nursing 2005; 17(1): 35-45.
42.
Weber M, Mazzotti N, Barzenski B, Silva T.
Evaluation of the quality of life in patients with atopic dermatitis
participating in support groups. J Am Acad Dermatol 2005; 52 (Suppl
1): 70.
43.
Blanchet-Bardon C, Corre J-M, Le C N.
Health-related quality of life in ichthyosis patients and family members.
J Am Acad Dermatol 2005; 52(Suppl 1): 110.
44.
Agredano Y, Alster T S, Bryan H A, Weiss S C.
Quality of life assessment of patients with port-wine stains receiving
flashlamp-pulsed dye laser treatment. J Am Acad Dermatol 2005;
52(Suppl 1):
45.
Holme S A, Anstey A V, Badminton M N, Elder G H.
UK prospective study on erythropoietic protoporphyria: quality of life
assessment. BJD 2005; 153
(Suppl 1): 41.
46.
Baron S E, Layton A, Goulden V. A pilot study of
hypnotherapy to treat adults and children with moderate to severe atopic
dermatitis. BJD 2005; 153 (Suppl 1): 37.
47.
Charman C R, Venn A J, Williams H, Bigby M.
Measuring atopic eczema severity visually. Arch Dermatol: 2005;
141: 1146-1151.
48.
McKenna S p, Whalley D, de Prost Y, Staab D, Huels S
J, Paul C F, van Assche D. Treatment of paediatric atopic dermatitis with
pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and
health-related quality of life. JEADV 2006; 20: 248-254.
49. Baron S, Layton A, Goulden V. A Pilot study of
hypnotherapy to treat adults and children with moderate to sever atopic
dermatitis. J Am Acad Dermatol 2006; 54: AB2
50. Shaw M, Goldsmith L, Morell D. The study of
targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
J Am Acad Dermatol 2006; 54: AB83
51
Weber M B, Soirefmann M, Mazzotti N G, Cestari T F.
Improvement of pruritus, clinical manifestations and quality of life of patients
with atopic dermatitis and their families after joining support groups. J
Am Acad Dermatol 2006; 54: AB87.
52
Holm E A, Wulf H C, Stegmann H, Jemec G B E.
Life quality assessment among patients with atopic eczema. BJD
2006; 54: 719-725.
53
Beattie P E, Lewis-Jones M S. A comparative
study of impairment of quality of life in children with skin diseases and
children with other chronic child diseases. BJD 2006 155: 145-151.
54
Hon K L E, Lam M C A, Kam W Y C, Leung T F, Wong K
Y, Lee K K C, Fok T F,
Ng P C. CDLQI, SCORAD and NESS: are they correlated? BJD 2006
155: 106-119.
55
Sunderkotter C, Weiss J M,
Bextermoller R. :Loffler ,. Schneider D. Post-market surveillance on
treatment of 5,665 patients with atopic dermatitis using the calcineurin
inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis
and on quality of life. J Dtsch Dermatol Ges 2006; 4: 301-306.
56
Holme S A, Anstey A V, Finlay A Y, Elder G H,
Badminton M N. Erythropoietic protoporphyria in the UK: clinical features
and effect on qualify of life. BJD 2006; 155: 574-581.
57
Hon K L E, Kam W Y C, Lam M C A, Leung T F, Ng P C.
CDLQI, SCORAD and NESS: are they correlated? Quality of Life
Research 2006; 15: 1551-1558.
58
Walker N, Lewis-Jones M S. Quality of life and
acne in Scottish adolescent schoolchildren: use of the Children’s Dermatology
Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI).
J Eur Acad Dermatol Venereol 2006; 20: 45-50.
59
Ganemo A, Svensson A, Lindberg M, Wahlgren C-F.
Quality of life in Swedish children with eczema. Acta Derm Venereol
2007; 87:345-349.
60
Hon K L E, Leung T F, Ng P C, Lam M C A, Kam W Y C,
Wong K Y, Lee K C K, Sung Y T, Cheng K F, Fok T F, Fung K P, Leung P C.
Efficacy and tolerability of a Chinese herbal medicine concoction for treatment
of atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Br J Dermatol 2007; 157: 357-363.
61
Clayton T H, Clark S M, Britton J, Pavolv S, Radev
S. A comparative study of the Children’s Dermatology Life Quality Index (CDLQI)
in paediatric dermatology clinics in the UK and Bulgaria. JEADV
2007; 21:
62
Taieb C, Martinsic M A, Nocera T, Bousetta S.
Atopic dermatitis and thermal therapies: evaluation in children under 15.
J Am Acad Dermatol 2008; P2314.
63
Shaw M, Morrell D S, Goldsmith L A. A Study of
Targeted Enhanced Patient care for Pediatric Atopic Dermatitis (STEP PAD).
Pediatric Dermatology 2008; 25: 19-24.
|